MEDICATIONS: PUBLIC POLICY OF ASAM:
RIGHTS AND RESPONSIBILITIES OF HEALTH CARE PROFESSIONALS IN THE USE OF OPIOIDS
FOR THE TREATMENT OF PAIN
A consensus document from the American Academy of Pain Medicine, the American
Pain Society and the American Society of Addiction Medicine.
Background
Health care professional (HCP) concerns regarding the potential for harm to
patients, as well as possible legal, regulatory, licensing or other third-party
sanctions related to the prescription of opioids, contribute significantly to
the mistreatment of pain. HCPs are obligated to act in the best interest of
their patients. This action may include the addition of opioid medication to the
treatment plan of patients whose symptoms include pain. Though many types of
pain are best addressed by non-opioid interventions, opioids are often indicated
as a component of effective pain treatment. It is sometimes a difficult medical
judgment as to whether opioid therapy is indicated in patients complaining of
pain because objective signs are not always present.
A decision whether to prescribe opioids may be particularly difficult in
patients with concurrent addictive disorders, or with risk factors for
addiction, such as a personal or family history of addictive disorder. For such
persons, exposure to potentially rewarding substances may reinforce drug taking
behavior and therefore present special risks. It is, nonetheless, a medical
judgment that must be made by a HCP in the context of the provider-patient
relationship based on knowledge of the patient, awareness of the patient's
medical and psychiatric conditions and on observation of the patient's response
to treatment. The selection of a particular opioid, or combination of opioids,
and the determination of opioid dose and therapeutic schedule similarly must be
based on full clinical understanding of a particular situation and cannot be
judged appropriate or inappropriate independent of such knowledge. All schedule
II-V opioids, including methadone, may be appropriate choices for pain control
in different circumstances; it is critical that clinicians understand the
special pharmacologic characteristics of each medication in order to prescribe
them safely and effectively for pain.
Despite appropriate medical practice, health care providers who prescribe
opioids for pain may occasionally be misled by patients who wish to obtain
medications for purposes other than pain treatment, such as diversion for
profit, recreational use or perpetuation of an addicted state. Physicians who
are willing to provide compassionate, ongoing medical care to challenging and
psychosocially stressed patients, where that treatment includes the prescription
of opioids, assume an additional obligation to understand the risks and
management of addictive disease because they risk complications of care more
often than physicians unwilling to treat this population.
Addiction to opioids may occur despite appropriate opioid therapy for pain in
some susceptible individuals. Persistent failure to recognize and provide
appropriate medical treatment for the disease of addiction is poor medical
practice and may become grounds for practice concern. Similarly, persistent
failure to use opioids effectively when they are indicated as part of the
treatment of pain, including in persons with active or recovering addiction, is
poor medical practice and may also become grounds for practice concern. It is
important to distinguish, however, between HCPs who are knowingly complicit in
diversion or other illegal prescribing activities and physicians who may
inappropriately prescribe opioids due to misunderstandings regarding addiction
or pain. HCPs traditionally have received little or no education on addiction or
clinical pain treatment in the course of training. This omission is likely a
basis for inadequate detection and management of addiction and inadequate
assessment and treatment of pain.
carisoproodol. xenicale
|